Literature DB >> 21281848

Pharmacotherapy for anxiety disorders in children and adolescents.

Ian Kodish1, Carol Rockhill, Sheryl Ryan, Chris Varley.   

Abstract

Anxiety disorders comprise the most prevalent mental health disorders among children and adults. Psychotherapy and pharmacotherapy are effective in improving clinical impairments from anxiety disorders and maintaining these improvements. This article discusses how to obtain a suitable diagnosis for anxiety disorders in youth for implementing appropriate treatments, focusing on the evidence base for pharmacologic treatment. Clinical guidelines are discussed, including Food and Drug Administration indications and off-label use of medications, and considerations for special populations and youth with comorbidities are highlighted. Findings suggest moderate effectiveness of medication, particularly selective serotonin reuptake inhibitors, in the treatment of anxiety disorders in youth.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281848     DOI: 10.1016/j.pcl.2010.10.002

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  8 in total

1.  Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.

Authors:  Jeffrey R Bishop; Fedra Najjar; Leah H Rubin; Stephen J Guter; Thomas Owley; Matthew W Mosconi; Suma Jacob; Edwin H Cook
Journal:  Pharmacogenet Genomics       Date:  2015-11       Impact factor: 2.089

Review 2.  SSRIs in a case of selective mutism.

Authors:  Katharina Manassis; David Avery
Journal:  J Psychiatry Neurosci       Date:  2013-01       Impact factor: 6.186

3.  Chronic fluoxetine dissociates contextual from auditory fear memory.

Authors:  Jeff Sanders; Mark Mayford
Journal:  Neurosci Lett       Date:  2016-08-31       Impact factor: 3.046

4.  Dual Cognitive and Biological Correlates of Anxiety in Autism Spectrum Disorders.

Authors:  Matthew J Hollocks; Andrew Pickles; Patricia Howlin; Emily Simonoff
Journal:  J Autism Dev Disord       Date:  2016-10

5.  Biopsychosocial Predictors of Quality of Life Outcomes in Pediatric Congenital Heart Disease.

Authors:  Michelle M Ernst; Bradley S Marino; Amy Cassedy; Carrie Piazza-Waggoner; Rodney C Franklin; Katherine Brown; Jo Wray
Journal:  Pediatr Cardiol       Date:  2017-10-04       Impact factor: 1.655

6.  Targeting Peripheral Somatosensory Neurons to Improve Tactile-Related Phenotypes in ASD Models.

Authors:  Lauren L Orefice; Jacqueline R Mosko; Danielle T Morency; Michael F Wells; Aniqa Tasnim; Shawn M Mozeika; Mengchen Ye; Anda M Chirila; Alan J Emanuel; Genelle Rankin; Ryann M Fame; Maria K Lehtinen; Guoping Feng; David D Ginty
Journal:  Cell       Date:  2019-08-08       Impact factor: 41.582

Review 7.  Pharmacotherapy of anxiety disorders: a critical review.

Authors:  Nastassja Koen; Dan J Stein
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

Review 8.  Nutritional Support of Neurodevelopment and Cognitive Function in Infants and Young Children-An Update and Novel Insights.

Authors:  Kathrin Cohen Kadosh; Leilani Muhardi; Panam Parikh; Melissa Basso; Hamid Jan Jan Mohamed; Titis Prawitasari; Folake Samuel; Guansheng Ma; Jan Mw Geurts
Journal:  Nutrients       Date:  2021-01-10       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.